Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel
Authors:
Open Access
- 1 February 2019
- journal article
- research article
- Published by BMJ in BMJ Open Gastroenterology
- Vol. 6 (1) , e000256
Abstract
Background and aims This article provides expert guidance on the management of pruritus symptoms in patients receiving obeticholic acid (OCA) as treatment for primary biliary cholangitis (PBC). PBC is a chronic, autoimmune cholestatic liver disease that affects intrahepatic bile ducts. If not adequately treated, PBC can lead to cholestasis and end-stage liver disease, which may require transplant. Timely treatment is therefore vital to patient health. Pruritus is a common symptom in patients with PBC. Additionally, the use of OCA to treat PBC can contribute to increased pruritus severity in some patients, adding to patient discomfort, decreasing patient quality of life (QoL), and potentially affecting patient adherence to OCA treatment. Methods In May 2018, a group of physician experts from the fields of gastroenterology, hepatology, and psychiatry met to discuss the management of pruritus in OCA-treated patients with PBC. Recognizing the importance of optimizing treatment for PBC, these experts developed recommendations for managing pruritus symptoms in the OCA-treated PBC patient based on their experience in clinical practice. Results These recommendations include a comprehensive list of management strategies (including over-the-counter, prescription, and alternative therapies), guidance on titration of OCA to minimize pruritus severity, and an algorithm that outlines a practical approach to follow up with patients receiving OCA, to better assess and manage pruritus symptoms. Conclusions Pruritus associated with OCA therapy is dose dependent and often manageable, and with the proper education and tools, most pruritus cases can be effectively managed to minimize treatment discontinuation.Keywords
This publication has 34 references indexed in Scilit:
- The TGR5 receptor mediates bile acid–induced itch and analgesiaJournal of Clinical Investigation, 2013
- Psychosomatic factors in pruritusClinics in Dermatology, 2013
- Visual Analogue Scale: Evaluation of the Instrument for the Assessment of PruritusActa Dermato-Venereologica, 2012
- Pathogenesis of cholestatic itch: Old questions, new answers, and future opportunitiesHepatology, 2012
- A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary CirrhosisDigestive and Liver Disease, 2010
- The 5-D itch scale: a new measure of pruritusBritish Journal of Dermatology, 2009
- Primary biliary cirrhosisSeminars in Immunopathology, 2009
- Primary biliary cirrhosis # †Hepatology, 2009
- Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trialHepatology, 2006
- Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosisGut, 2005